These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29 related articles for article (PubMed ID: 15683517)
1. Electromuscular incapacitating devices discharge and risk of severe bradycardia. Havranek S; Neuzil P; Linhart A Am J Forensic Med Pathol; 2015 Jun; 36(2):94-8. PubMed ID: 25710795 [TBL] [Abstract][Full Text] [Related]
2. Blood lactate concentration after exposure to conducted energy weapons (including TASER® devices): is it clinically relevant? Jauchem JR Forensic Sci Med Pathol; 2013 Sep; 9(3):386-94. PubMed ID: 23605975 [TBL] [Abstract][Full Text] [Related]
3. Cardiac fibrillation risk of TASER X-26 dart mode application. Leitgeb N; Niedermayr F; Loos G; Neubauer R Wien Med Wochenschr; 2011 Dec; 161(23-24):571-7. PubMed ID: 22037697 [TBL] [Abstract][Full Text] [Related]
7. Cardiac effects of electrical stun guns: does position of barbs contact make a difference? Lakkireddy D; Wallick D; Verma A; Ryschon K; Kowalewski W; Wazni O; Butany J; Martin D; Tchou PJ Pacing Clin Electrophysiol; 2008 Apr; 31(4):398-408. PubMed ID: 18373757 [TBL] [Abstract][Full Text] [Related]
8. Effects of cocaine intoxication on the threshold for stun gun induction of ventricular fibrillation. Lakkireddy D; Wallick D; Ryschon K; Chung MK; Butany J; Martin D; Saliba W; Kowalewski W; Natale A; Tchou PJ J Am Coll Cardiol; 2006 Aug; 48(4):805-11. PubMed ID: 16904553 [TBL] [Abstract][Full Text] [Related]
9. Taser dart-to-heart distance that causes ventricular fibrillation in pigs. Wu JY; Sun H; O'Rourke AP; Huebner S; Rahko PS; Will JA; Webster JG IEEE Trans Biomed Eng; 2007 Mar; 54(3):503-8. PubMed ID: 17355063 [TBL] [Abstract][Full Text] [Related]
10. Effect of electrode surface area on thresholds for AC stimulation and ventricular fibrillation. Patel SG; Malkin RA IEEE Trans Biomed Eng; 2007 Oct; 54(10):1829-36. PubMed ID: 17926681 [TBL] [Abstract][Full Text] [Related]
11. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations). Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697 [TBL] [Abstract][Full Text] [Related]
13. Using the upper limit of vulnerability to assess defibrillation efficacy at implantation of ICDs. Swerdlow CD; Shehata M; Chen PS Pacing Clin Electrophysiol; 2007 Feb; 30(2):258-70. PubMed ID: 17338725 [TBL] [Abstract][Full Text] [Related]